Veracyte | VCYT - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
Agenus USD 10.56M 13.04M 2025-12
Agilent USD 465M 11M 2026-03
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 41.74M 4.28M 2026-03
Bruker USD 242.1M 5.1M 2026-03
Heron Therapeutics USD 23.74M 605K 2025-12
Illumina USD 272M 11M 2026-03
Intrexon USD 10.31M 41K 2024-06
Karyopharm Therapeutics USD 9.56M 17.63M 2025-12
Laboratory Of America USD 551M 12.4M 2026-03
Ligand Pharmaceuticals USD 20.84M 4.19M 2026-03
Myriad Genetics USD 122.3M 6.7M 2025-12
Rigel Pharmaceuticals USD 27.04M 1M 2024-09
Roche Holding CHF 7.28B 3.99B 2025-12
Sangamo BioSciences USD 9.64M 1.83M 2024-06
Siemens EUR 3.56B 45M 2026-03
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Veracyte USD 50.84M 7.53M 2026-03
Waters USD 394M 153.99M 2026-03